Skip to main content

CITADEL ADVISORS LLC

Position in DRTS — Alpha Tau Medical Ltd.

CIK 1423053 MIAMI, FL

Position in DRTS

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$774,411
+$524,169 QoQ
Shares Held
61,559
+73.9% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 74 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DRTS Over Time

Shares Held

Position Value (USD)

Derivatives in DRTS

reported options exposure · as of Jun 30, 2026
CallValue
$1,510,858
CallShares
120,100
PutValue
$2,438,004
PutShares
193,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. DRTS ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DRTS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $774,411 61,559
2026-06-30 $1,510,858 120,100
2026-06-30 $2,438,004 193,800
2026-03-31 $207,858 29,400
2026-03-31 $250,242 35,395
2026-03-31 $534,492 75,600
2025-12-31 $124,740 25,200
2025-09-30 $273,306 60,600
2025-06-30 $207,414 66,479
2025-03-31 $150,218 59,848
2024-09-30 $38,796 16,301
2022-03-31 $184,882 15,668